Clinical Trial Update: BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women [NA]

View source ↗

Summary

This clinical trial update indicates that BTL Industries Ltd. is recruiting for a study evaluating the BTL-699-2 and HPM-6000UF devices to improve depressive sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Sexual Dysfunction
• Urinary Incontinence

Drugs mentioned

• BTL-699-2
• HPM-6000UF

Snippet

Sponsor: BTL Industries Ltd. | Conditions: Depressive Symptoms, Urinary Incontinence | NA | Status: RECRUITING